Case Study: Sanofi’s acquisition of Ablynx for $4.8 bn
French drugmaker Sanofi has agreed to acquire Belgian biotech company Ablynx for 3.9 billion euros ($4.8 billion). This is second deal of... Read More
Case Study: Ablynx – Merck KGaA Strategic deal
Preset: Ablynx is a biopharmaceutical company engaged in the discovery and development of Nanobodies. In July 2015 Merck & Co. and Ablynx... Read More